NASDAQ: DCGODocgo Inc Stock
$2.28+0.04 (+1.79%)
Updated Apr 29, 2025
DCGO Price
$2.28
Fair Value Price
N/A
Market Cap
$232.52M
52 Week Low
$2.02
52 Week High
$5.68
P/E
11.4x
P/B
0.72x
P/S
0.7x
PEG
N/A
Dividend Yield
N/A
Revenue
$616.56M
Earnings
$19.99M
Gross Margin
34.6%
Operating Margin
5.89%
Profit Margin
3.2%
Debt to Equity
0.44
Operating Cash Flow
$70M
Beta
1.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DCGO Overview
DocGo, Inc. provides medical transportation services to health care providers in the U.S. and UK. Offerfings include ambulance services and wheelchair transportation services. It also offers mobile health services at homes and offices, COVID-19 testing, and on-site healthcare support at sporting events and concerts. DocGo was incorporated in 2015 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DCGO's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
DCGO
Ranked#37 of 42
Ranked#37 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.56 | A | |
| $12.65 | A | |
| $14.03 | A |
Be the first to know about important DCGO news, forecast changes, insider trades & much more!
DCGO News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DCGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DCGO is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DCGO is good value based on its earnings relative to its share price (11.4x), compared to the US market average (29.19x)
P/E vs Market Valuation
DCGO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more DCGO due diligence checks available for Premium users.
Valuation
DCGO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.4x
Industry
14.71x
Market
29.19x
DCGO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DCGO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
DCGO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
4.32x
DCGO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DCGO's financial health
Profit margin
Revenue
$120.8M
Net Income
-$3.3M
Profit Margin
-2.7%
DCGO's Earnings (EBIT) of $36.31M... subscribe to Premium to read more.
Interest Coverage Financials
DCGO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$455.6M
Liabilities
$140.4M
Debt to equity
0.44
DCGO's short-term assets ($304.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DCGO's short-term assets ($304.49M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DCGO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
DCGO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$12.9M
Investing
-$5.6M
Financing
-$7.9M
DCGO's operating cash flow ($70.34M)... subscribe to Premium to read more.
Debt Coverage Financials
DCGO vs Medical Care Facility Stocks
Docgo Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.